Daiichi, Toshiba, and Toshiba Hokuto to Develop Array-Based IVD | GenomeWeb
NEW  YORK (GenomeWeb News) - Daiichi Pure Chemicals, Toshiba, and Toshiba Hokuto Electronics plan to co-develop microarray-based in vitro diagnostic systems and chips, the companies said today.
 
Under the agreement, the companies will first develop an IVD for human papilloma virus.
 
Daiichi Pure Chemicals and Toshiba have collaborated on the system since January 2004.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.